no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A segment of Staphylococcus aureus clumping factor A with fibrinogen-binding activity (ClfA221–550) inhibits platelet-plug formation in mice
|
Liu, Chao-Zong |
|
2007 |
121 |
2 |
p. 183-191 9 p. |
article |
2 |
Comparison of two immunochemical assays for measuring thrombin-activatable fibrinolysis inhibitor concentration with a functional assay in patients with acute coronary syndrome
|
Skeppholm, Mika |
|
2007 |
121 |
2 |
p. 175-181 7 p. |
article |
3 |
Cystic fibrosis heterozygotes do not have increased platelet activation
|
Tarnow, Inge |
|
2007 |
121 |
2 |
p. 159-162 4 p. |
article |
4 |
Decreased levels of PAI-1 and alpha2-antiplasmin contribute to enhanced fibrinolytic activity in divers
|
Radziwon, P. |
|
2007 |
121 |
2 |
p. 235-240 6 p. |
article |
5 |
Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications induced by peroxynitrite: Functional consequences
|
Nowak, Pawel |
|
2007 |
121 |
2 |
p. 163-174 12 p. |
article |
6 |
Dynamics of platelet activation in diabetic and non-diabetic subjects during the course of an acute myocardial infarction
|
Karlsson, Fredrik |
|
2007 |
121 |
2 |
p. 269-273 5 p. |
article |
7 |
Editorial Board
|
|
|
2007 |
121 |
2 |
p. IFC- 1 p. |
article |
8 |
Efficacy of antithrombin in the prevention of microvascular thrombosis during endotoxemia: An intravital microscopic study
|
Sorg, Heiko |
|
2007 |
121 |
2 |
p. 241-248 8 p. |
article |
9 |
Evaluation of reticulated platelets in patients with sickle cell diseases
|
Noronha, J.F.A. |
|
2007 |
121 |
2 |
p. 259-267 9 p. |
article |
10 |
Expression of interleukin-18 in coronary plaque obtained by atherectomy from patients with stable and unstable angina
|
Nishihira, Kensaku |
|
2007 |
121 |
2 |
p. 275-279 5 p. |
article |
11 |
In vivo response to vascular injury in the absence of factor IX: Examination in factor IX knockout mice
|
Gui, Tong |
|
2007 |
121 |
2 |
p. 225-234 10 p. |
article |
12 |
Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis
|
Santos, Joana C. |
|
2007 |
121 |
2 |
p. 213-223 11 p. |
article |
13 |
Prognostic significance of delays in diagnosis of pulmonary embolism
|
Jiménez Castro, David |
|
2007 |
121 |
2 |
p. 153-158 6 p. |
article |
14 |
Pulsed-high intensity focused ultrasound enhanced tPA mediated thrombolysis in a novel in vivo clot model, a pilot study
|
Stone, Michael J. |
|
2007 |
121 |
2 |
p. 193-202 10 p. |
article |
15 |
The use of low molecular weight heparins in pediatrics: Two cases that highlight potential risks to patient safety
|
Gupta, Archna |
|
2007 |
121 |
2 |
p. 281-282 2 p. |
article |
16 |
Tissue factor and tissue factor pathway inhibitor levels in coronary artery disease: Correlation with the severity of atheromatosis
|
Lima, Luciana Moreira |
|
2007 |
121 |
2 |
p. 283-287 5 p. |
article |
17 |
Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplate® analyzer—comparison with two flow cytometric methods
|
Mueller, Thomas |
|
2007 |
121 |
2 |
p. 249-258 10 p. |
article |
18 |
VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: Involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinases
|
Ratel, David |
|
2007 |
121 |
2 |
p. 203-212 10 p. |
article |
19 |
Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC–PCI complex concentration and/or soluble thrombomodulin antigen and activity
|
Strandberg, Karin |
|
2007 |
121 |
2 |
p. 145-151 7 p. |
article |